Hiromichi Akizawa

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

High Fat Diet Induced

Top Venues

Pharmaceuticals (Basel, Switzerland)

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Miho Shukuri, Satoru Onoe, Tsubasa Karube, Risa Mokudai, Hayate Wakui, Haruka Asano, Shin Murai, Hiromichi Akizawa
Assessment of Radiolabelled Derivatives of R954 for Detection of Bradykinin B1 Receptor in Cancer Cells: Studies on Glioblastoma Xenografts in Mice. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Miho Shukuri, Satoru Onoe, Tsubasa Karube, Risa Mokudai, Hayate Wakui, Haruka Asano, Shin Murai, Hiromichi Akizawa
Assessment of Radiolabelled Derivatives of R954 for Detection of Bradykinin B1 Receptor in Cancer Cells: Studies on Glioblastoma Xenografts in Mice. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Miho Shukuri, Satoru Onoe, Tsubasa Karube, Risa Mokudai, Hayate Wakui, Haruka Asano, Shin Murai, Hiromichi Akizawa
Assessment of Radiolabelled Derivatives of R954 for Detection of Bradykinin B1 Receptor in Cancer Cells: Studies on Glioblastoma Xenografts in Mice. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Yuki Mizuno, Kohta Kimura, Satoru Onoe, Miho Shukuri, Yuji Kuge, Hiromichi Akizawa
Influence of Linker Molecules in Hexavalent RGD Peptides on Their Multivalent Interactions with Integrin αvβ3. Journal of medicinal chemistry 64 (21) (2021)
Yuki Mizuno, Tomoya Uehara, Chun-Wei Jen, Hiromichi Akizawa, Yasushi Arano
The synthesis of a 99m Tc-labeled tetravalent targeting probe upon isonitrile coordination to 99m Tc I for enhanced target uptake in saturable systems. RSC advances 9 (45) (2019)